NanoViricides Inc. (NNVC)

[JG36]

You failed to grasp my point entirely. If you really believe that NNVC will be at $100 a share after Fluicide approval then you could rationally hold the stock if you believe it has better than 0.5% chance of succeeding.

Me, I take into account the reality that there will be more rounds of share dilution before those phase 3 trials are completed. (Or equivalently, NNVC gets funding from big pharma in return for giving up a fair fraction of the profits.) So while NNVC might well be far above $5 if all goes well, I certainly wouldn't count on $100.